EMCDDA Home
  • EN
Search

Table TDI-106. New clients entering outpatient treatment by primary drug and age at first use, 2011 or most recent year available

Part (vii) New cannabis outpatient clients by country and age at first use

Country<1515-1920-2425-2930-3435-3940-4445+Age knownAge not knownTotal
Belgium4865712002125815940
Bulgaria16000000707
Czech Republic129148140021029430324
Denmark43843143644129291021031
Germany2866400530174221296729519259220
Estonia163:::::::::
Ireland455334291301182423847
Greece11930130700004574461
Spain12547385946613062221946715115028653
France299525803718026107::766:
Italy2730247013451167425252548109715781
Cyprus3220370310103101311
Latvia31031650100532073
Lithuania:::::::::::
Luxembourg:::::::::::
Hungary2981271337115401476208802088
Malta12182111:::3:
Netherlands90410091143222572209519394034
Austria148345338002153710547
Poland4255121:::::2:
Portugal514626038800004525457
Romania729194100060060
Slovenia11234::1:::::
Slovakia226911310001060106
Finland946300000581169
Sweden18935620530005730573
United Kingdom687383882422140864718::1098:
Croatia79332315220::125:
Turkey:::::::::::
Norway:::::::::::
Total20974221273718745350146989128224935235582
 

Notes:

: Indicates no data are available

(1) Data are from 2010.

(2) In 2011 around 27% of all clients and 32% of new clients were registered as not known / missing for the primary drug category. Caution should be made when comparing data over time.

(3) In 2010 Latvia submitted a new dataset with a more precise TDI EMCDDA definition. Caution should be made when comparing data with previous years.

(4) Data are from 2010. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

(5) In 2010 came into implementation a new national information system implying methodological changes particularly in the registration criteria. Caution should be made when comparing 2010 data with previous years.

(6) Data are from 1st of April 2010 to 31st March 2011.

For more information relative to the treatment centre type, please see Table TDI-7.

See also Table TDI-11 part(i), part(ii)

‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012- Table TDI Outpatient Treatment Centres

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 26 April 2013